Biotechnology Companies' Annual Reports & Investor Relations Material

582 Companies

ILMN

Illumina

San Diego-based Illumina, Inc. is a life science tools and integrated systems company that has been a key player in the analysis of genetic variation and function. Operating through its Core Illumi...

Illumina Annual Report 2023

Healthcare Biotechnology NASDAQ 5001-10,000

VVUS

VIVUS, Inc

VIVUS Inc. is a biopharmaceutical company that is currently focused on developing therapies that tackle diseases such as obesity, sleep apnea, diabetes, and male sexual health. One of its key produ...

VIVUS, Inc Annual Report 2018

Healthcare Biotechnology NASDAQ 51-200

AMAG

AMAG Pharmaceuticals, Inc.

AMAG Pharmaceuticals is a specialty pharmaceutical company with a focus on maternal health, anemia, and cancer supportive care. The company markets three key products: Makena, an injection to reduc...

AMAG Pharmaceuticals, Inc. Annual Report 2018

Healthcare Biotechnology NASDAQ 201-500

NVLN

Novelion Therapeutics Inc.

Novelion Therapeutics is a biopharmaceutical company that aims to improve the lives of individuals with rare diseases by developing new standards of care. The company focuses on advancing its portf...

Novelion Therapeutics Inc. Annual Report 2017

Healthcare Biotechnology NASDAQ 201-500

ALXN

Alexion Pharmaceuticals

Alexion Pharmaceuticals is a biopharmaceutical company that specializes in the development and commercialization of biologic therapeutic products. The company's focus is on products for severe and ...

Alexion Pharmaceuticals Annual Report 2019

Healthcare Biotechnology NASDAQ 1001-5000

EOF

Ecofibre Limited

Ecofibre Limited is a company that specializes in breeding, growing, manufacturing, marketing, and selling hemp products in both the United States and Australia. The company has three segments, inc...

Ecofibre Limited Annual Report 2023

Healthcare Biotechnology ASX 51-200

SLRX

Salarius Pharmaceuticals

Houston-based Salarius Pharmaceuticals Inc. is a promising clinical-stage biotech company that is focused on developing new therapies for cancers with unmet medical needs. Its cutting-edge lead can...

Salarius Pharmaceuticals Annual Report 2023

Healthcare Biotechnology NASDAQ 1-10

SCPH

scPharmaceuticals

Pharmaceutical company scPharmaceuticals Inc. is making headway in the development and commercialization of a range of pharmaceutical products. Among its offerings is FUROSCIX, the company's lead p...

scPharmaceuticals Annual Report 2023

Healthcare Biotechnology NASDAQ 11-50

MNOV

MediciNova Inc.

MediciNova Inc., a California-based biopharmaceutical company, is focused on the development of innovative and small molecule therapeutics to address serious diseases with unmet medical needs in th...

MediciNova Inc. Annual Report 2023

Healthcare Biotechnology NASDAQ 1-10

KTOV

Kitov Pharma Ltd.

Kitov Pharma Ltd. is a clinical-stage company dedicated to developing innovative therapies to combat tumor immune evasion and drug resistance in cancer treatment. Their pipeline includes NT219, a s...

Kitov Pharma Ltd. Annual Report 2018

Healthcare Biotechnology NASDAQ 1-10

BYSI

BeyondSpring, Inc.

BeyondSpring Inc., a prominent biopharmaceutical company that is currently in the clinical stage, focuses on providing potential cancer therapies. The company, which comprises various subsidiaries,...

BeyondSpring, Inc. Annual Report 2023

Healthcare Biotechnology NASDAQ 51-200

CRIS

Curis Inc

Biotech company, Curis, Inc., is making strides in the discovery and development of drug candidates for the treatment of human cancers in the United States. The company's clinical stage drug candid...

Curis Inc Annual Report 2023

Healthcare Biotechnology NASDAQ 51-200

NGM

NGM Biopharmaceuticals, Inc.

NGM Biopharmaceuticals, Inc. is a biopharmaceutical company with a focus on developing innovative treatments for liver and metabolic diseases, retinal diseases, and cancer. The company's pipeline i...

NGM Biopharmaceuticals, Inc. Annual Report 2023

Healthcare Biotechnology NASDAQ 51-200

APM

Aptorum Group Limited

Aptorum Group Limited, a biopharmaceutical company based in London, is focused on the development and commercialization of therapeutic products for the treatment of infectious diseases and cancer. ...

Aptorum Group Limited Annual Report 2023

Healthcare Biotechnology NASDAQ 11-50

DXB

Dimerix Limited

Australian biopharmaceutical company Dimerix Limited is currently developing DMX-200 for respiratory complications in COVID-19 patients with two ongoing Phase 3 clinical trials. The drug is also un...

Dimerix Limited Annual Report 2019

Healthcare Biotechnology ASX 1-10